NCT03190005View on ClinicalTrials.gov

Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions

Stable Angina

Interventions

DRUG

clopidogrel

routine Dual antiplatelet therapy after stent implantation, then check PRU(platelet reactivity unit)

DRUG

Placebos

no medication, healthy subjects.

Trial Locations (1)

Unknown

Taipei city hospital, Taipei

All Listed Sponsors

lead

Taipei City Hospital

OTHER_GOV

NCT03190005 - Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity) | Biotech Hunter | Biotech Hunter